Search results
Results from the WOW.Com Content Network
For the treatment of the withdrawal/negative affect symptom domain of cannabis use disorder, medications may work by alleviating restlessness, irritable or depressed mood, anxiety, and insomnia. [58] Bupropion , which is a norepinephrine–dopamine reuptake inhibitor , has been studied for the treatment of withdrawal with largely poor results ...
There is also evidence that regular marijuana use can speed up the start of symptoms of mood disorders like bipolar disorder and major depression, along with anxiety disorders — especially in ...
So are the alternatives for anxiety. Medications like buspirone or benzodiazepines are also prescribed for anxiety symptoms, although the latter can lead to dependence and withdrawal symptoms ...
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
Anxiety and depression have been found to increase susceptibility to marijuana use. [52] This is due to a desire to alleviate the symptoms of these experiences through marijuana use. Chronic users who use for anxiolytic purposes will even develop dependencies on cannabis, making it difficult to cope with anxiety when the drug is absent.
Forty-four percent used drugs, such as marijuana, as sleep aides. The same percentage cited drug use as a way to "stop worrying about a problem or forget bad memories." And 40% said they used to ...
Heavy marijuana use may fuel anxiety disorders, new research finds. This age group is most at risk. Erin Prater. February 5, 2024 at 6:30 PM. Getty Images. ... or make their symptoms worse.
Reported user negative effects include palpitations, paranoia, intense anxiety, nausea, vomiting, confusion, poor coordination, and seizures. There have also been reports of a strong compulsion to re-dose, withdrawal symptoms, and persistent cravings. [12] There have been several deaths linked to synthetic cannabinoids.